— Olmed announced a multi-year revenue milestone reflecting the continued development of digital healthcare retail operations. The company reported growth from approximately PLN 70 million to nearly PLN 300 million over a five-year period, representing an expansion of activity within online pharmacy services and related categories.
The reported figures correspond with a period of operational transition in which digital systems, fulfilment processes, and product access channels have been structured to support increasing transaction volumes. The development reflects ongoing changes in how healthcare-related products are accessed through online environments, where purchasing behavior is influenced by reliability, clarity of information, and consistency in service delivery.
Olmed operates within a category where customer expectations extend beyond standard e-commerce factors. The handling of health-related products requires alignment with regulatory structures, verified sourcing, and controlled distribution processes. The reported revenue increase coincides with the continued integration of these elements into digital operations, including order management systems, inventory coordination, and delivery execution.
The growth period also includes the expansion of product categories such as over-the-counter medicines, supplements, and related pharmacy categories. These categories are associated with routine healthcare needs, where repeat purchasing patterns depend on familiarity with processes and stability in service performance. Digital infrastructure has been developed to support access to these products while maintaining operational continuity.
Leadership transition has taken place during the same timeframe. Jakub Lisinski assumed executive roles between 2020 and 2023, with responsibilities covering operational oversight and digital development. The transition represents a continuation of family-led management within a business originally established in Lodz, Poland. The current structure combines existing pharmacy operations with digital systems designed to handle increased scale.
The reported revenue development occurs within a broader shift in Central and Eastern Europe, where online healthcare retail continues to expand. Market activity indicates a gradual increase in the use of digital channels for purchasing health-related products. This environment includes a range of operators with varying approaches to logistics, sourcing, and customer interaction. Within this context, operational models are being adjusted to align with both regulatory expectations and customer behavior patterns.
Olmed has implemented changes in fulfilment processes to support order handling timelines and delivery coordination. These changes include adjustments to warehouse operations, order verification steps, and shipment tracking procedures. The aim of these adjustments is to maintain consistency in order processing across different product types and transaction volumes.
Digital interface development has also formed part of the operational transition. Product listings, informational content, and navigation structures have been arranged to present details related to dosage, usage, and availability in a structured format. This approach reflects the role of information clarity in healthcare retail, where purchasing decisions are often linked to understanding of product characteristics.
The company continues to operate under licensed pharmacy requirements, which define the handling and distribution of medicines and related products. Compliance with these requirements forms part of the operational framework within which digital expansion has taken place. This includes adherence to standards related to storage, verification, and customer transaction processes.
The revenue milestone reflects the aggregation of these operational components over time. The figures indicate the scale of activity achieved through the combination of pharmacy-based processes and digital infrastructure. The period under review includes ongoing adjustments to both areas as the company continues to operate within the online healthcare retail environment.
About Company
Olmed is a licensed online pharmacy in Poland, founded in Lodz, Poland, by the Lisinski family. The company operates across over-the-counter medicines, supplements, and related pharmacy categories, combining pharmacy-based operations with digital systems for product access and order fulfilment.
Contact Info:
Name: Spolka z ograniczona odpowiedzialnoscia Sp. K.
Email: Send Email
Organization: OLMED
Phone: +48 42 233 49 09
Website: http://www.aptekaolmed.pl
Release ID: 89187027
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.